172 related articles for article (PubMed ID: 20432232)
1. The pericyte and stromal cell marker CD248 (endosialin) is required for efficient lymph node expansion.
Lax S; Hardie DL; Wilson A; Douglas MR; Anderson G; Huso D; Isacke CM; Buckley CD
Eur J Immunol; 2010 Jul; 40(7):1884-9. PubMed ID: 20432232
[TBL] [Abstract][Full Text] [Related]
2. Targeting endosialin/CD248 through antibody-mediated internalization results in impaired pericyte maturation and dysfunctional tumor microvasculature.
Rybinski K; Imtiyaz HZ; Mittica B; Drozdowski B; Fulmer J; Furuuchi K; Fernando S; Henry M; Chao Q; Kline B; Albone E; Wustner J; Lin J; Nicolaides NC; Grasso L; Zhou Y
Oncotarget; 2015 Sep; 6(28):25429-40. PubMed ID: 26327620
[TBL] [Abstract][Full Text] [Related]
3. The stromal cell antigen CD248 (endosialin) is expressed on naive CD8+ human T cells and regulates proliferation.
Hardie DL; Baldwin MJ; Naylor A; Haworth OJ; Hou TZ; Lax S; Curnow SJ; Willcox N; MacFadyen J; Isacke CM; Buckley CD
Immunology; 2011 Jul; 133(3):288-95. PubMed ID: 21466550
[TBL] [Abstract][Full Text] [Related]
4. CD248/Endosialin is dynamically expressed on a subset of stromal cells during lymphoid tissue development, splenic remodeling and repair.
Lax S; Hou TZ; Jenkinson E; Salmon M; MacFadyen JR; Isacke CM; Anderson G; Cunningham AF; Buckley CD
FEBS Lett; 2007 Jul; 581(18):3550-6. PubMed ID: 17628549
[TBL] [Abstract][Full Text] [Related]
5. Endosialin (TEM1, CD248) is a marker of stromal fibroblasts and is not selectively expressed on tumour endothelium.
MacFadyen JR; Haworth O; Roberston D; Hardie D; Webster MT; Morris HR; Panico M; Sutton-Smith M; Dell A; van der Geer P; Wienke D; Buckley CD; Isacke CM
FEBS Lett; 2005 May; 579(12):2569-75. PubMed ID: 15862292
[TBL] [Abstract][Full Text] [Related]
6. CD248/endosialin critically regulates hepatic stellate cell proliferation during chronic liver injury via a PDGF-regulated mechanism.
Wilhelm A; Aldridge V; Haldar D; Naylor AJ; Weston CJ; Hedegaard D; Garg A; Fear J; Reynolds GM; Croft AP; Henderson NC; Buckley CD; Newsome PN
Gut; 2016 Jul; 65(7):1175-85. PubMed ID: 26078290
[TBL] [Abstract][Full Text] [Related]
7. CD248 facilitates tumor growth via its cytoplasmic domain.
Maia M; DeVriese A; Janssens T; Moons M; Lories RJ; Tavernier J; Conway EM
BMC Cancer; 2011 May; 11():162. PubMed ID: 21549007
[TBL] [Abstract][Full Text] [Related]
8. A differential role for CD248 (Endosialin) in PDGF-mediated skeletal muscle angiogenesis.
Naylor AJ; McGettrick HM; Maynard WD; May P; Barone F; Croft AP; Egginton S; Buckley CD
PLoS One; 2014; 9(9):e107146. PubMed ID: 25243742
[TBL] [Abstract][Full Text] [Related]
9. Genetic Deletion of the Stromal Cell Marker CD248 (Endosialin) Protects against the Development of Renal Fibrosis.
Smith SW; Croft AP; Morris HL; Naylor AJ; Huso DL; Isacke CM; Savage CO; Buckley CD
Nephron; 2015; 131(4):265-77. PubMed ID: 26633297
[TBL] [Abstract][Full Text] [Related]
10. Targeting the activated microenvironment with endosialin (CD248)-directed CAR-T cells ablates perivascular cells to impair tumor growth and metastasis.
Ash SL; Orha R; Mole H; Dinesh-Kumar M; Lee SP; Turrell FK; Isacke CM
J Immunother Cancer; 2024 Feb; 12(2):. PubMed ID: 38413223
[TBL] [Abstract][Full Text] [Related]
11. Endosialin/TEM 1/CD248 is a pericyte marker of embryonic and tumor neovascularization.
Bagley RG; Honma N; Weber W; Boutin P; Rouleau C; Shankara S; Kataoka S; Ishida I; Roberts BL; Teicher BA
Microvasc Res; 2008 Nov; 76(3):180-8. PubMed ID: 18761022
[TBL] [Abstract][Full Text] [Related]
12. Multimerin-2 is a ligand for group 14 family C-type lectins CLEC14A, CD93 and CD248 spanning the endothelial pericyte interface.
Khan KA; Naylor AJ; Khan A; Noy PJ; Mambretti M; Lodhia P; Athwal J; Korzystka A; Buckley CD; Willcox BE; Mohammed F; Bicknell R
Oncogene; 2017 Nov; 36(44):6097-6108. PubMed ID: 28671670
[TBL] [Abstract][Full Text] [Related]
13. CD248 Regulates Wnt Signaling in Pericytes to Promote Angiogenesis and Tumor Growth in Lung Cancer.
Hong CL; Yu IS; Pai CH; Chen JS; Hsieh MS; Wu HL; Lin SW; Huang HP
Cancer Res; 2022 Oct; 82(20):3734-3750. PubMed ID: 35950912
[TBL] [Abstract][Full Text] [Related]
14. The mesenchymal stem cell marker CD248 (endosialin) is a negative regulator of bone formation in mice.
Naylor AJ; Azzam E; Smith S; Croft A; Poyser C; Duffield JS; Huso DL; Gay S; Ospelt C; Cooper MS; Isacke C; Goodyear SR; Rogers MJ; Buckley CD
Arthritis Rheum; 2012 Oct; 64(10):3334-43. PubMed ID: 22674221
[TBL] [Abstract][Full Text] [Related]
15. Endosialin is expressed on stromal fibroblasts and CNS pericytes in mouse embryos and is downregulated during development.
MacFadyen J; Savage K; Wienke D; Isacke CM
Gene Expr Patterns; 2007 Jan; 7(3):363-9. PubMed ID: 16965941
[TBL] [Abstract][Full Text] [Related]
16. Endosialin-Expressing Pericytes Promote Metastatic Dissemination.
Viski C; König C; Kijewska M; Mogler C; Isacke CM; Augustin HG
Cancer Res; 2016 Sep; 76(18):5313-25. PubMed ID: 27635044
[TBL] [Abstract][Full Text] [Related]
17. Interaction with CD68 and Regulation of GAS6 Expression by Endosialin in Fibroblasts Drives Recruitment and Polarization of Macrophages in Hepatocellular Carcinoma.
Yang F; Wei Y; Han D; Li Y; Shi S; Jiao D; Wu J; Zhang Q; Shi C; Yang L; Song W; Zhang J; Han Y; Zhang R; Yang AG; Dimitrov DS; Zhao A; Qin W; Wen W
Cancer Res; 2020 Sep; 80(18):3892-3905. PubMed ID: 32591411
[TBL] [Abstract][Full Text] [Related]
18. Endosialin: molecular and functional links to tumor angiogenesis.
Kontsekova S; Polcicova K; Takacova M; Pastorekova S
Neoplasma; 2016; 63(2):183-92. PubMed ID: 26774137
[TBL] [Abstract][Full Text] [Related]
19. Role of CD248 as a potential severity marker in idiopathic pulmonary fibrosis.
Bartis D; Crowley LE; D'Souza VK; Borthwick L; Fisher AJ; Croft AP; Pongrácz JE; Thompson R; Langman G; Buckley CD; Thickett DR
BMC Pulm Med; 2016 Apr; 16(1):51. PubMed ID: 27080864
[TBL] [Abstract][Full Text] [Related]
20. Endosialin/TEM-1/CD248 regulates pericyte proliferation through PDGF receptor signaling.
Tomkowicz B; Rybinski K; Sebeck D; Sass P; Nicolaides NC; Grasso L; Zhou Y
Cancer Biol Ther; 2010 Jun; 9(11):908-15. PubMed ID: 20484976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
